Taysha Gene Therapies
TSHA
TSHA
59 hedge funds and large institutions have $54.7M invested in Taysha Gene Therapies in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
51% less capital invested
Capital invested by funds: $111M → $54.7M (-$56.2M)
Holders
59
Holding in Top 10
–
Calls
$89K
Puts
–
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.15M | |
| 3 | +$1.02M | |
| 4 |
Millennium Management
New York
|
+$804K |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$614K |
Top Sellers
| 1 | -$4.34M | |
| 2 | -$4.27M | |
| 3 | -$1.82M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.57M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$665K |